Valiant Organics Ltd

Valiant Organics Ltd

₹ 425 -1.40%
24 Jun - close price
About

Valiant Organics is engaged in the business of Manufacturing of chemicals for Agro Intermediate and Pharma.

Key Points

Overview[1]
Valiant Organics Limited is a specialty chemical manufacturing company in India since 1984. Key chemistries include Chlorination, Hydrogenation, Ammonolysis, Acetylation, Sulphonation, Methoxylation etc. Key industries using the products are agrochemicals, pharmaceuticals, dyes, pigments, and veterinary medications.

  • Market Cap 1,173 Cr.
  • Current Price 425
  • High / Low 570 / 368
  • Stock P/E
  • Book Value 241
  • Dividend Yield 0.24 %
  • ROCE 0.96 %
  • ROE -1.14 %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.26% over past five years.
  • Company has a low return on equity of 8.99% over last 3 years.
  • Promoter holding has decreased over last 3 years: -4.89%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
170 184 213 261 291 235 232 218 227 177 182 141 177
134 145 176 216 246 208 201 189 183 156 165 138 179
Operating Profit 37 39 37 45 44 26 31 28 44 20 17 4 -2
OPM % 21% 21% 17% 17% 15% 11% 14% 13% 19% 11% 9% 3% -1%
8 3 0 2 1 1 0 6 1 6 0 0 2
Interest 1 2 2 1 2 3 2 3 3 4 4 4 7
Depreciation 5 6 6 8 7 6 7 7 8 8 8 9 9
Profit before tax 38 34 29 37 36 18 23 24 34 14 5 -9 -16
Tax % 28% 22% 27% 26% 25% 24% 25% 24% 24% 25% 26% 22% 32%
28 27 22 28 27 14 17 19 26 10 4 -7 -11
EPS in Rs 10.16 9.81 7.92 10.16 10.01 5.08 6.29 6.82 9.65 3.82 1.44 -2.43 -3.86
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
34 43 59 52 73 121 606 584 574 948 912 677
28 34 48 36 55 94 426 410 417 783 780 638
Operating Profit 6 8 11 16 18 26 179 174 157 165 131 40
OPM % 18% 19% 19% 30% 25% 22% 30% 30% 27% 17% 14% 6%
1 1 1 1 2 1 5 5 17 6 7 9
Interest 0 1 1 0 0 0 2 1 3 6 11 19
Depreciation 1 1 1 1 2 2 12 13 19 27 28 34
Profit before tax 6 8 11 16 18 25 171 165 152 137 100 -5
Tax % 34% 32% 34% 35% 35% 35% 29% 25% 25% 25% 24% 41%
4 6 7 10 12 16 121 124 115 103 76 -3
EPS in Rs 57.57 79.14 103.86 14.03 15.92 13.97 103.65 51.00 42.20 37.91 27.83 -1.10
Dividend Payout % 38% 27% 50% 71% 16% 23% 6% 11% 12% 9% 4% 0%
Compounded Sales Growth
10 Years: 32%
5 Years: 2%
3 Years: 6%
TTM: -26%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -110%
Stock Price CAGR
10 Years: %
5 Years: -13%
3 Years: -35%
1 Year: -22%
Return on Equity
10 Years: 20%
5 Years: 15%
3 Years: 9%
Last Year: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0 0 0 4 4 6 6 12 27 27 27 28
Reserves 15 18 21 19 42 53 254 374 475 576 638 637
Preference Capital 0 0 0 0 0 0 0 2 0 0 0
2 5 8 1 1 1 53 117 149 305 220 216
10 14 11 17 23 36 89 127 154 175 221 262
Total Liabilities 28 37 40 41 69 96 402 629 806 1,083 1,106 1,142
10 11 11 12 26 31 130 256 478 509 610 630
CWIP 0 0 1 0 0 0 66 129 46 110 70 86
Investments 2 2 2 2 7 7 20 34 42 53 53 54
15 24 26 26 35 58 187 210 240 410 373 371
Total Assets 28 37 40 41 69 96 402 629 806 1,083 1,106 1,142

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
8 3 6 18 9 18 77 160 115 -11 182 85
-3 -2 -1 -1 -1 -6 -88 -191 -135 -120 -90 -65
-5 -2 -5 -16 -4 -5 2 35 22 146 -108 -23
Net Cash Flow -0 -2 -0 0 4 7 -8 5 1 14 -17 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 71 90 74 71 88 112 73 69 74 97 85 113
Inventory Days 45 94 42 36 97 44 45 47 85 58 70 91
Days Payable 91 81 7 50 130 154 80 97 135 76 101 166
Cash Conversion Cycle 25 103 110 57 55 2 37 20 25 80 54 38
Working Capital Days 5 44 101 66 70 42 55 34 51 90 68 68
ROCE % 37% 43% 43% 61% 52% 48% 91% 41% 27% 18% 12%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
41.65% 40.56% 39.01% 39.00% 38.46% 38.43% 38.41% 38.41% 38.37% 37.90% 37.90% 37.77%
1.85% 1.93% 1.98% 1.73% 1.99% 0.68% 0.57% 0.18% 0.30% 0.19% 0.69% 1.14%
1.91% 1.93% 1.90% 1.92% 1.89% 2.13% 1.94% 0.89% 0.88% 0.92% 0.87% 0.43%
54.59% 55.58% 57.11% 57.35% 57.66% 58.78% 59.07% 60.52% 60.43% 60.99% 60.54% 60.65%
No. of Shareholders 22,80128,20731,98332,79934,53942,49743,10644,30245,84848,59849,05050,460

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls